Skip to main content

Advertisement

Log in

Carotid Intima Media Thickness in Patients with Obstructive Sleep Apnea: Comparison with a Community-Based Cohort

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Background

The impact of obstructive sleep apnea (OSA) on the development of atherosclerotic cardiovascular disease (CVD) in the absence of overt CVD or risk factors is unclear. Our purpose was to assess whether patients with OSA without overt CVD or risk factors have subclinical atherosclerosis as evaluated by carotid intima medial thickness (CIMT) compared to matched controls.

Methods

We measured CIMT in patients >40 years old, who underwent polysomnography for suspected OSA and did not have a history of CVD or risk factors (smoking, hypertension, diabetes, hyperlipidemia). OSA severity was classified according to apnea–hypopnea index. Serum levels of high-sensitivity C-reactive protein, fibrinogen, and lipids were assessed and relationships with OSA severity explored. CIMT measurements from patients with OSA were compared those of to age-, gender-, and BMI-matched controls from a community-based cohort without known CVD or OSA.

Results

Fifty-one patients were studied. Of these, patients with severe OSA had an increased CIMT compared to patients without OSA, but the relationship was not significant after controlling for age (p = 0.10). However, 37 patients had OSA and were matched to 105 controls. CIMT was significantly increased in OSA patients versus controls (0.77 vs. 0.68 mm, p = 0.03). The difference between patients and controls was greater for patients with severe OSA (0.83 vs. 0.71 mm) than for patients with mild-to-moderate OSA (0.71 vs. 0.67 mm).

Conclusions

Patients with OSA but without a history of or risk factors for CVD have increased CIMT compared to a BMI-, age-, and gender-matched cohort. This provides evidence that OSA is an independent risk factor for the development of CVD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Leung RS, Bradley TD (2001) Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 164(12):2147–2165

    Article  CAS  PubMed  Google Scholar 

  2. Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165(9):1217–1239

    Article  PubMed  Google Scholar 

  3. Marin JM, Carrizo SJ, Vicente E, Agusti AGN (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053

    Article  PubMed  Google Scholar 

  4. Bounhoure JP, Galinier M, Didier A, Leophonte P (2005) Sleep apnea syndromes and cardiovascular disease. Bull Acad Natl Med 189(3):445–459 (discussion 460–464)

    PubMed  Google Scholar 

  5. Mancini GB, Dahlof B, Diez J (2004) Surrogate markers for cardiovascular disease: structural markers. Circulation 109(25 Suppl 1):IV22–IV30

    PubMed  Google Scholar 

  6. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 146(6):483–494

    Article  CAS  PubMed  Google Scholar 

  7. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu C, Liu C, Alaupovic P, Kwong-Fu H, Azen SP (1996) Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med 124(6):548–556

    Article  CAS  PubMed  Google Scholar 

  8. Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN (2002) ARBITER: arterial biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 106(16):2055–2060

    Article  CAS  PubMed  Google Scholar 

  9. American Academy of Sleep Medicine (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22:667–689

    Google Scholar 

  10. Mancini GB, Abbott D, Kamimura C, Yeoh E (2004) Validation of a new ultrasound method for the measurement of carotid artery intima medial thickness and plaque dimensions. Can J Cardiol 20(13):1355–1359

    PubMed  Google Scholar 

  11. Lear SA, Humphries KH, Kohli S, Frohlich JJ, Birmingham CL, Mancini GB (2007) Visceral adipose tissue, a potential risk factor for carotid atherosclerosis: results of the Multicultural Community Health Assessment Trial (M-CHAT). Stroke 38(9):2422–2429

    Article  PubMed  Google Scholar 

  12. Bergstralh EJ, Kosanke JL (1995) Computerized matching of controls. Technical Report Series No. 56, Department of Health Science Research, Mayo Clinic, Rochester

  13. Silvestrini M, Rizzato B, Placidi F, Baruffaldi R, Bianconi A, Diomedi M (2002) Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 33(7):1782–1785

    Article  PubMed  Google Scholar 

  14. Suzuki T, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Yamauchi M, Kimura H (2004) Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 27:129–133

    PubMed  Google Scholar 

  15. Campos-Rodriguez F, Martinez-Garcia MA, Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM (2012) Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment. Ann Intern Med 156:115–122

    Article  PubMed  Google Scholar 

  16. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342(19):1378–1384

    Article  CAS  PubMed  Google Scholar 

  17. Minoguchi K, Yokoe T, Tanaka A, Ohta S, Hirano T, Yoshino G, O’Donnell CP, Adachi M (2006) Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respir J 28(2):378–385

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by an operating grant from the Vancouver General Hospital Division of Cardiology CV Research Fund, and a Canadian Institutes of Health Research (CIHR) Sleep Team Grant. The M-CHAT cohort study was funded by CIHR. Dr. Ayas was supported by an Established Clinician Scientist Award from Vancouver Coastal Health Research Institute. Dr. Lear is the Pfizer/Heart and Stroke Foundation Chair in Cardiovascular Prevention Research at St. Paul’s Hospital.

Conflict of interest

The authors have no conflicts of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Graham C. Wong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fox, N., Ayas, N., Park, J.E. et al. Carotid Intima Media Thickness in Patients with Obstructive Sleep Apnea: Comparison with a Community-Based Cohort. Lung 192, 297–303 (2014). https://doi.org/10.1007/s00408-014-9556-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-014-9556-y

Keywords

Navigation